Saugeen First Nation, a Neyaashiinigmiing based indigenous business has officially confirmed their plans to build an industrial park to harvest cannabis.
According to terms laid out in an agreement, Saugeen First Nation will partner with Wiisag Corporation to make this possible. Jake Linklater, co founder and executive chairman of the Wiisag was quoted as referring to this as a legacy deal, that could be bigger than Saugeen First Nation’s Bruce to Milton hydro line deal.
It’s also apparent that Linklater has invested his faith in Saugeen First Nation as well. He had even mentioned in a phone interview on Sunday that future projections for the company could reach an annual $2 million – $5 million easily.
Bryan Hendry, Wiisag Corporation’s marketing and communications director has elaborated on the details too. He highlighted how Saugeen First Nation had 750 acres ready to be converted into a full fledged industrial park which will include outdoor and indoor marijuana harvesting. He also mentioned that there would be plans for retail components as well, sometime in the future.
Hendry also described how they would have to contend with tough timelines too, as they intend on beginning on cultivation as early as June. However, seedlings would have to be planted and readied much before that if they are to target harvest sometime in September.
The Saugeen harvest will be overseen by Burnstown Farms, a company that has prior experience in growing marijuana outdoors in the Ottawa Valley. The same company had earlier tweeted about their plans on raising $1 million to be invested later in a premier organic cannabis farm.
Of course, the 750 acres of cannabis is a ‘notional concept’ says Linklater. For now, only 25 acres will be used by Saugeen to harvest the marijuana. The structure is a pretty simple one too, that comprises of a fenced off lot of land surrounded by lighting, cameras, and some indoor building close by for processing of the product. Gradually, more plants will be cultivated.
The product being referred to here is the oil, that will be extracted from the plants and be used for developing medicines in the first two years of the project. The company has plans on hiring some twenty employees right away to get started on initial plans. They will hire another thirty more people in across the next four weeks. Linklater later added that there will be a job fair to help support this part of the project.
Saugeen First Nation have their own plan of action too, where they will make use of greenhouses to grow even more cannabis plants and that retail cannabis sales are part of the bigger picture.
Based on how things pan out over the next two years, both sides might consider foraying into the adult recreational pot market. But that discussion will have to wait till after the outdoor grow takes place and is a success. Of course, there are certain ethical ties connected to that part of the project, where the Saugeen community will also have a say in whether thy would want to go down that path or not.
Wiisag Ventures, the holder of the outdoor grow license, is still waiting on their approval, which they say should come in the next few weeks. Linklater says that they are the first to own such a license and that Saugeen First nation will own 51% of it.
The Wiisag Corporation was set up to oversee funding for this project to share, develop expertise on cannabis. Other than building an indigenous cannabis brand, their other objectives include partnering with indigenous communities and manage, fund and even operate their cultivation practices. Wiisag will also work on research and development, providing access to global markets.
Linklater stated that First Nation communities will be viewed as partners who have 51% share in the license and the rest belonging to Wiisag. This is to support a business model where various strains of the same plant will be grown by several of these partners, subject to differences in growing conditions.
He added that he hasn’t received any notice on whether the Neyaashiinigmiing First Nation wishes to be involved in their project.
One silver lining as pointed out by Hendry is the Indigenous Service Canada, and the changes they made to regulations concerning the cannabis funding ventures, breweries and distilleries on reserves.
California welcomes Cannabis Restaurants and Cafes with ‘flower’ and ‘budtender’ service
Just like any good chef planning to open a brand new restaurant, Andrea Drummer wants to get her work done just right. But her plantain-mango salsa with lamb chops will not be matched with beer or wine.
Instead, a “budtender”- widely popular in the industry as ganjiers, as in ganja sommeliers- will assist guests at the soon-to-open Lowell Farms cannabis cafe to pair their meal with the perfect amount of farm-to-table cannabidiol.
Drummer said that a kush is slightly bit more pungent, so it tastes better with a stew or a meal like meat or beef product. A lightly lemon profile goes well with a fish. One of her personal favourites, Blue Dream, tastes really good with both sweet and savory. Drummer tells that she has done done it with bread puddings, and with ice cream, but she’s also tried it with octopus.
When the vintage-like, rustic, hemp-filled cafe with 220-seat capacity will open, it will be the first of its kind in the United States: a cozy place for tourists and locals to relish high-quality meals and smoke a joint in public. Other restaurants are soon to follow.
But if they are planning to incorporate weed on the menu, restaurateurs in the city will have to work their way through a complicated workflow of regulations. The progressive city had approved an ordinance in 2017 and allowed businesses for this purpose.
Jackie Subeck said that they are building the boat as they’re on the water, with cannabis. Subeck plans to launch a cannabis cafe, spa, clinic and serves as the chairwoman of the cannabis legislative subcommittee for the West Hollywood Chamber of Commerce.
States that have legalized cannabis for recreation will watch the town pull it off. In Mayallowing cannabis lounges, Colorado Gov. Jared Polis (D) signed a bill. Cannabis restaurants may eventually become as normal as wine bars if legalization remains apace.
Sean Black, the co-founder of Lowell Herb Co., the cannabis organization launching the cafe said that whatever West Hollywood will be doing now will be followed by other blue states, three years later.
According to the proposition 64, cannabis is legalized in California, but consuming cannabis in public is still banned.
When a research session on the subject was held by the West Hollywood City Council in 2017, it was determined that access to locations for smoking was an issue of social equity.
John Leonard, the city’s community and legislative affairs manager said that many people in the city are renters, and they may not be allowed to smoke cannabis in their apartments. These people who stay on rent are forced to smoke in their cars or public places, and run a higher risk for getting arrested for that.
But this wasn’t the only reason why cannabis was legalized for smoking in public by the council.
Leonard said that people enjoy the nightlife in West Hollywood, so the cannabis legalization was sort of a natural evolution, that people can easily enjoy while staying in the West Hollywood in a hotel, or they could go out to cafes or bars to smoke a joint, and now they can go for cannabis consumption as well.
Cannabinoid, a hemp-derived compound was legalized from the federal government in December 2018 under the Farm Bill Act. The substance was removed from the list of Controlled Substances and made legal for production, processing, distribution and consumption.
CBD is widely popular for its medical benefits. From treating stress, anxiety, depression, sleeplessness to reducing acute pains, aches, inflammation, swelling, irritation, CBD has been used by numerous people for various health ailments.
There are public places for marijuana use elsewhere in California and Colorado, but there are many lounges connected to dispensaries or vape clubs that resemble a dingy cellar. These places are quite different from what West Hollywood had in mind when it launched applications for 16 on-site consumption licenses in May 2018.
The process drew a lot of attention and more than 300 applicants, who were scored on multiple factors such as social equity and innovation. The top eight participants in each of the five categories were permitted to proceed.
Drummer’s application was amongst the highest scorers in the category for cannabis consumption in lounge (vaping, smoking and edible), featured a “bright and airy oasis” with tableside “flower” service- hand-rolled cannabis buds into joints. Drummer also called for a full-fledged menu infused with cannabis, which Drummer has been creating for several years as a private chef for her clients including comedian Chelsea Handler.
HOLY SMOKE Nate Diaz puffs cannabis oil with fans before UFC 241 fight
The fans favourite Nate Diaz makes his octagon return on Saturday competing with Anthony Pettis, his old rival in his home of California. Diaz hasn’t fought since August 2016 when he lost to Conor McGregor in a majority decision at the UFC 202. The Stockton native reminded his fans of his unique personality by smoking a cannabidiol on the stage.
After his rematch defeat to The Notorious, Diaz infamously smoked CBD oil-which was banned by the United States Anti-Doping Agency at the time. However, the USADA has made cannabidiol legal in and out of the competition.
Diaz took advantage of the updated rules by producing his own Game Up Nutrition CBD line. The UFC also signed an agreement with Aurora Cannabis to assist fighters in taking supplements after a fight to treat aches and pains.
Diaz told ESPN that he was the pioneer for the UFC fighters to have the once prohibited drug legal.
Diaz said if they saw how he landed a great CBD deal for the UFC. He further stated that CBD is now present in every sport and athletic competition- from football to basketball to wrestling rings, CBD is legal and UFC is paid out!
He added that everyone has jumped on the CBD bandwagon because of him. He apparently started the CBD movement, says Diaz.
His brother Nick was given a five-year ban after he failed the post-fight drug test for marijuana metabolites after his loss to Anderson Silva in 2013.
In a pre-fight drug screening, Silva tested positive for oxazepam, drostanolone, temazepam and androstane, and the fight was proclaimed a no contest. Nick spent about four months appealing his failed marijuana test and gradually got it reduced to 18 months with a £82,000 fine.
However, the MMA veteran has not battled since the middleweight battle at UFC 183 after all the time spent appealing the decision. Because Nick failed to pay his NSAC penalties, in his high-profile battles with McGregor he was not qualified to corner his brother.
What is CBD?
CBD or cannabidiol is a hemp derived compound which is an anti-inflammatory chemical with healing capabilities. There are many medical benefits of using CBD, as claimed by several patients who have used it to treat their anxiety, inflammation, stress, depression and other ailments.
The federal government in the United States legalized hemp-derived cannabinoids under the Farm Bill in december 2018, thereby removing CBD from the list of controlled substances. According to the federal regulations, CBD products are legal for production, processing, sales and consumption, however the maximum limit for THC is 0.3% per unit. If any product contains traces of THC amounting to more than 0.3%, the product will be considered illegal.
Many states have legalized hemp derived CBD, but there is still some hesitation among consumers about the safety and effects of CBD. There is not much evidence that backs up the medicinal claims of CBD.
The Food and Drug Administration (FDA) held a public meeting in May to discuss the regulatory framework for CBD and its other products. The meeting was attended by several renowned scientists, researchers, law enforcement officials, consumers, business leaders and many others.
The agency is yet to declare any official statement about CBD’s regulatory framework, however it has warned companies not to market or advertise their CBD products as a treatment to prescription drugs or with medicinal benefits.
It recently issued a warning letter to Curaleaf for advertising their CBD products claiming medical benefits, which is strictly prohibited by the agency. A spokesperson from the FDA said that the agency is highly concerned about the health of consumers and want to ensure that CBD is a safe product to consume in any form. Till the time the agency clears off CBD as a safe substance, companies have to take additional precautions to ensure they are not violating any regulations laid out by the FDA.
NHS blocks Cannabis-based medicines for routine use, demands for more evidence for its medical claims
Despite of the government legalizing cannabis-based drugs, the compound has been in a controversy ever since it was removed from the list of Controlled Substances Act. The NHS has finally declared its say in the matter and blocked CBD as there is negligible science and evidence to support the medical claims of CBD.
The National Institute for Health and Care Excellence (Nice) called for fast-tracked clinical trials yesterday after concluding that it could not recommend medicinal products that are CBD-based for regular usage.
Sajid Javid decriminalized drugs last November following the high-profile campaign in support of Alfie Dingley, a child with severe epilepsy whose mother was forced to seek treatment abroad. However, without the approval by Nice, only a handful of doctors are qualified and willing to recommend CBMPs (cannabis-based medical products), meaning the medicines are almost impossible to get in practice.
Patient charities were devastated after hearing the conclusion of Nice, saying that it denies the chance of effectivement treatment using cannabis-based medicines to hundreds if not thousands of people.
Any accompnying report by the NHS England blamed the “rapid-rescheduling” of CBMPs in last year for leading to high expectations from the patients and their families that they could access cannabis-based medicines and drugs on the NHS.
Apart from blocking the regular use of cannabis-based medicines for epilepsy treatments on the NHS, the Nice draft guidance also denied to recommend Sativex, another cannabis-based epilepsy medicine, based on tha fact that it is not cost-effective.
But the organization approved Nabilone, a synthetic based cannabis-based medicine for treating cancer patients battling with side-effects of chemotherapy.
Chemotherapy is often known to cause physical as well as mental stress in patients. Many people feel intense pain and depression post their chemo treatment.
Hannah Deacon’s son, Alfie Dingley is one of the two patients with an NHS prescription. Deacon said that there are hundreds of thousands of people around the world who are using cannabis-based medicines to get better and improve their health. Not only are these patients having a positive impact on their medical conditions but it is also improving their lifestyle and health overall.
She pointed out that Canada, the United States and many G7 countries have legalized mecial cannabis. She further added that UK is persistently pushing for reinventing the wheel for no reason, and the people who suffer from their decisions are patients in dire need of a treatment.
CBPMs were redesignated from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations last year, which implied that specialist doctors can recommend and prescribe them to patients. However, in the absence of Nice guidelines, they may be personally liable if anything goes in the opposite direction.
Chief pharmaceutical officer at NHS, Dr. Keith Ridge said that without sufficient evidence to back up the medical claims of cannabis based medicines, they are trying to provide balanced potential benefits against significant harms when deciding whether or not to prescribe medical cannabis to children who suffer from severe epilepsy.
Nice is considered to be as one of the most rigorous agencies in the world because of its staunch regulations and high demands for copious evidence from clinical trials before they allow drugs as effective, safe and cost-effective.
NHS England pledged to begin “one or more” randomized control trials associated with CBMPs for children with severe treatment-resistant for epilepsy. It will also provide full genome sequencing to all the children that are under consideration for treatment with medical cannabis.
However, the Medical Cannabis Clinicians Soceity accused the Nice committee of being biased against cannabis as it is wrong to apply the same standards for evidence regarding CBMPs as other drugs.
Genevieve Edwards, from the MS Society, said that MS is painful, relentless and disabling and not a single patient with MS has gained any significant beneift from medical cannabis since it was legalized nine months ago.
The drug approved for routine use by the NHS is Nabilone, a cannabis-based drug which is a synthetic product that resembles the effects of THC, tetrahydro cannabinoid, the chemical responsible for making people ‘high’ while smoking pot or weed.